Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$48,652,123
+$19,026,616 QoQ
Shares Held
653,224
+63.7% QoQ
Ownership
0.334%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#59
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Jun 30, 2026
CallValue
$195,152,496
CallShares
2,620,200
PutValue
$73,400,040
PutShares
985,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. BBIO ranks #9 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in BBIO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $195,152,496 2,620,200
2026-06-30 $48,652,123 653,224
2026-06-30 $73,400,040 985,500
2026-03-31 $29,625,507 398,943
2026-03-31 $61,167,962 823,700
2026-03-31 $177,080,396 2,384,600
2025-12-31 $204,251,247 2,670,300
2025-12-31 $42,176,586 551,400
2025-12-31 $37,279,390 487,376
2025-09-30 $38,887,478 748,700
2025-09-30 $17,756,520 341,866
2025-09-30 $154,698,096 2,978,400
2025-06-30 $27,400,862 634,573
2025-06-30 $126,823,978 2,937,100
2025-06-30 $25,795,732 597,400
2025-03-31 $107,357,135 3,105,500
2025-03-31 $17,468,221 505,300
2025-03-31 $25,571,567 739,704
2024-12-31 $96,193,664 3,505,600
2024-12-31 $15,275,848 556,700
2024-12-31 $33,594,298 1,224,282
2024-09-30 $15,444,036 606,600
2024-09-30 $79,893,480 3,138,000
2024-09-30 $18,207,897 715,157
2024-06-30 $17,139,519 676,649
2024-06-30 $75,767,096 2,991,200
2024-06-30 $21,571,028 851,600
2024-03-31 $31,093,152 1,005,600
2024-03-31 $16,245,368 525,400
2024-03-31 $1,804,274 58,353
2023-12-31 $15,110,491 374,300
2023-12-31 $30,059,502 744,600
2023-12-31 $4,130,456 102,315
2023-09-30 $16,900,533 640,900
2023-09-30 $10,635,021 403,300
2023-09-30 $10,749,809 407,653
2023-06-30 $6,765,807 393,361
2023-06-30 $14,521,960 844,300
2023-06-30 $5,185,800 301,500
2023-03-31 $8,709,606 525,308
2023-03-31 $5,652,122 340,900
2023-03-31 $3,999,096 241,200
2022-12-31 $591,441 77,617
2022-12-31 $419,100 55,000
2022-12-31 $332,994 43,700
2022-09-30 $2,564,946 258,043
2022-09-30 $238,560 24,000
2022-09-30 $349,888 35,200
2022-06-30 $448,487 49,393
2022-06-30 $2,461,588 271,100